Matti Mintz Mintz

Medicine & Life Sciences

1. Amygdala 100%
2. Seizures 75%
3. Visual Evoked Potentials 70%
4. Classical Conditioning 68%
5. Amphetamine 66%
6. Substantia Nigra 65%
7. Learning 62%
8. Dopamine 61%
9. Corpus Striatum 58%
10. Cerebellum 48%
11. Antipsychotic Agents 45%
12. Anxiety 42%
13. Machado-Joseph Disease 42%
14. RU 5135 37%
15. Schizophrenia 32%
16. Anxiety Disorders 28%
17. Brain 27%
18. Prefrontal Cortex 26%
19. Catalepsy 26%
20. Electrodes 26%
21. Electroshock 25%
22. Vestibulo-Ocular Reflex 24%
23. Fear 23%
24. Evoked Potentials 23%
25. Dihydroxyphenylalanine 23%
26. Eye Movements 23%
27. Ventral Tegmental Area 22%
28. Kainic Acid 22%
29. Picrotoxin 20%
30. Direction compound 20%
31. Ventral Striatum 19%
32. Robotics 18%
33. Haloperidol 18%
34. Psychological Extinction 18%
35. Pharmaceutical Preparations 17%
36. Electroencephalography 17%
37. Acceleration 17%
38. Cerebellar Nuclei 17%
39. Oxidopamine 16%
40. Acetylcholine 16%
41. Catatonia 16%
42. Injections 16%
43. Actihaemyl 16%
44. 1-(2 (diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine 16%
45. Analgesia 15%
46. Amidines 15%
47. Eyelid Conditioning 15%
48. Skin 15%
49. Levodopa 14%
50. Comorbidity 14%